Lindsay M. Boyce

TL;DR: In this article, the authors provided updated clinical practice guidelines from the Society for Integrative Oncology on the use of integrative therapies for specific clinical indications during and after breast cancer treatment, including anxiety/stress, depression/mood disorders, fatigue, quality of life/physical functioning, chemotherapy-induced nausea and vomiting, lymphedema, chemotherapyinduced peripheral neuropathy, pain, and sleep disturbance.

TL;DR: Organ specific immune-related adverse events are uncommon with anti-PD-1 drugs but the risk is increased compared with control treatments, and general adverse events related to immune activation are largely similar.

TL;DR: Trends in contouring guidelines are assessed, with evidence supporting a correlation between treatment planning and patient outcomes, although variation exists in the approach to the consensus process.

TL;DR: Available evidence suggests food can be effective at ameliorating cancer treatment-related toxicities and improving prognosis, but more research is needed.

TL;DR: Most author guidelines in the institutional sample did not address SR/MA methodological quality and when consulting with teams embarking on SRs/MAs, librarians should not expect author guidelines to provide details about the requirements of the target journals.